Photo by sharonmccutcheon from unsplash
Atrial fibrillation/ flutter (AF) is a common comorbidity in patients with heart failure (HF). We examined the influence of AF on the response to the selective cardiac myosin activator, omecamtiv… Click to show full abstract
Atrial fibrillation/ flutter (AF) is a common comorbidity in patients with heart failure (HF). We examined the influence of AF on the response to the selective cardiac myosin activator, omecamtiv mecarbil (OM), in patients with HFrEF. COSMIC-HF (NCT 01786512) was a Phase 2 multicenter, randomized,
Keywords:
atrial fibrillation;
omecamtiv mecarbil;
mecarbil patients;
heart failure
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!